Journals / Turkish Journal of Gastroenterology / 2017 / Cilt: 28 - Sayı: 1

Promotional effect of nonalcoholic fatty liver disease on Gallstone disease: A systematic review and meta-analysis

Pages
31–39
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, overall results remain controversial.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/Aims: Growing evidence indicates that nonalcoholic fatty liver disease (NAFLD) and gallstone disease (GD) share the same risk factors, and that NAFLD may be associated with the occurrence of GD.
📊
Key Findings & Data:The pooled prevalence of GD in cases with NAFLD was 17% (95% CI: 0.12-0.23).
💡
Conclusion & Impact:However, overall results remain controversial.
🔬Design:Lab & Field Experiment
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Background/Aims: Growing evidence indicates that nonalcoholic fatty liver disease (NAFLD) and gallstone disease (GD) share the same risk factors, and that NAFLD may be associated with the occurrence of GD. However, overall results remain controversial. The aim of this study is to perform a meta-analysis to assess the relationship between GD and NAFLD.Materials and Methods: Five databases (PubMed, Medline, Embase, Web of Science, and Cochrane Library) were queried, and observational studies that assessed the association between GD and NAFLD were selected. We pooled the prevalence of GD in participants with NAFLD, and compared the prevalence of GD in NAFLD and non-NAFLD groups in four trials.Results: Twelve studies met our inclusion criteria. The pooled prevalence of GD in cases with NAFLD was 17% (95% CI: 0.12-0.23). Compared with the non-NAFLD group, NAFLD was significantly correlated with GD (OR: 1.40, 95% CI: 1.23-1.59). Additional analyses reveal that participants in the GD group included more females (OR: 1.95, 95% CI: 1.36-2.79), were older (WMD: 6.61, 95% CI: 3.80-9.42), and had higher BMIs (WMD: 1.63, 95% CI: 0.62-2.65) in the population with NAFLD, compared to the non-GD group.Conclusion: GD prevalence in NAFLD patients is higher than that in the general population. Furthermore, the occurrence of GD is significantly associated with the female sex, age and BMI in NAFLD patients.

🔖

Cite This Article

SHEN, S., GONG, J., WANG, X., CHEN, L., QİN, S., HUANG, L., CHEN, Y., REN, H., YANG, Q., HU, H. (2017). Promotional effect of nonalcoholic fatty liver disease on Gallstone disease: A systematic review and meta-analysis. Turkish Journal of Gastroenterology, Cilt: 28 - Sayı: 1, 31–39. https://ajindex.com/articles/410207

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Pan JJ, Fallon MB. Gender and racial differences in nonalcoholic fatty liver disease. World J Hepatol 2014; 6: 274-83. [CrossRef] Korean Association for the Study of the Liver (KASL). KASL clini- cal practice guidelines: management of nonalcoholic fatty liver disease. Clin Mol Hepatol 2013; 19: 325-48. [CrossRef] Chalasani N, Younossi Z, Lavine JE, et al; American Gastroentero- logical Association; American Association for the Study of Liver Diseases; American College of Gastroenterologyh. The diagno- sis and management of non-alcoholic fatty liver disease: prac- tice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and Ameri- can College of Gastroenterology. Gastroenterology 2012; 142: 1592-609. [CrossRef] Kim D, Kim WR, Kim HJ, Therneau TM. Association between non- invasive fibrosis markers and mortality among adults with nonal- coholic fatty liver disease in the United States. Hepatology 2013; 57: 1357-65. [CrossRef] Salamone F, Bugianesi E. Nonalcoholic fatty liver disease: the hepatic trigger of the metabolic syndrome. J Hepatol 2010; 53: 1146-7. [CrossRef] Adams LA, Harmsen S, St Sauver JL, et al. Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study. Am J Gastroenterol 2010; 105: 1567-73. [CrossRef] Adams LA, Lymp JF, St Sauver J, et al. The natural history of nonal- coholic fatty liver disease: a population-based cohort study. Gas- troenterology 2005; 129: 113-21. [CrossRef] Byrne CD, Olufadi R, Bruce KD, Cagampang FR, Ahmed MH. Met- abolic disturbances in non-alcoholic fatty liver disease. Clin Sci (London) 2009; 116: 539-64. [CrossRef] Vernon G, Baranova A, Younossi ZM. Systematic review: the epi- demiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011; 34: 274-85. [CrossRef] Attili AF, Carulli N, Roda E, et al. Epidemiology of gallstone disease in Italy: prevalence data of the Multicenter Italian Study on Cho- lelithiasis (M.I.COL.). Am J Epidemiol 1995; 141: 158-65.
  2. Barbara L, Sama C, Morselli Labate AM, et al. A population study on the prevalence of gallstone disease: the Sirmione Study. Hepa- tology 1987; 7: 913-7. [CrossRef] Loria P, Dilengite MA, Bozzoli M, et al. Prevalence rates of gallstone disease in Italy. The Chianciano population study. Eur J Epidemiol 1994; 10: 143-50. [CrossRef] Nomura H, Kashiwagi S, Hayashi J, et al. Prev